← All stocks

OnKure Therapeutics, Inc.

OKUR Net buying
CIK 0001637715 #4079 in the set updated 21 Sep 2026
Bought (120 mo)
$36.39M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$5.19M
$0.00 on a plan · $98.06K straight out of an exercise
Sold at will
$5.09M
18 of 19 sales
Net
+$31.20M
+$31.30M against sales at will

By person

20 insiders · 59 transactions
Insider
Role
Bought
Sold
Net
Holding
Worth
Change
New Enterprise Associates 15, L.P. entity
10% owner
$10.00M (1)
+$10.00M
4,785,494
$21.04M
Novo Holdings A/S entity
10% owner
$10.00M (1)
$709.74K (1)
+$9.29M
3,330,337
$14.64M
Muralidhar Bali
Director
$4.90M (11)
+$4.90M
2,073,957
$9.12M
O'Donnell Niall
Director
$4.00M (2)
+$4.00M
4,252,426
$18.69M
+106.1%
Cormorant Asset Management, LP entity
Former 10% Owner
$3.41M (2)
−$3.41M
0
$0.00
−100.0%
RiverVest Venture Fund III, L.P. entity
10% owner
$3.00M (1)
+$3.00M
2,409,220
$10.59M
+762.5%
ACORN BIOVENTURES, L.P.
10% owner
$2.59M (2)
+$2.59M
2,839,674
$12.48M
+97.2%
Leonard Braden Michael
Former 10% owner of RPHM
$1.73M (11)
+$1.73M
447,815
$1.97M
Johnson Wendy S.
Chief Development Officer
$949.76K (1)
−$949.76K
0
$0.00
Hall Ashley
Chief Development Officer
$98.06K (1) scheduled
−$98.06K
39,600
$174.09K
+312.5%
Cruse Michael
Chief Operating Officer
$67.31K (7)
+$67.31K
45,455
$199.83K
+1,320%
FLESHER GREGORY J.
President and CEO
$64.00K (1)
+$64.00K
109,600
$481.83K
+6,750%
Jindal Vineet R.
Chief Financial Officer
$37.18K (1)
+$37.18K
36,600
$160.90K
+2,188%
Leverone Jason A.
Chief Financial Officer
$14.17K (7)
−$14.17K
18,802
$82.66K
+164.6%
Saccomano Nicholas A
President and CEO
$4.00K (7)
−$4.00K
11,247
$49.45K
+40.6%
GREY MICHAEL G
Director
134,084
$589.47K
+17.7%
Dorenbaum Alejandro
Chief Medical Officer
30,000
$131.89K
+34.2%
Manke Isaac
Director
20,583
$90.49K
Mathers Edward T
Director
15,310
$67.31K
Carruthers R Michael
Director
4,939
$21.71K

No percentages here. This company's share count has moved by a factor of 3.0 over the window, from 13,673,565 to 40,496,309 shares. A split, a merger or a large issue changes what the company is, and a holding measured at one point in that run is not a fraction of it at another.

Nothing of that kind in this period.

What was left out

Form 4 filings counted 131
Amendments (4/A) skipped 2
Filings about a different issuer 0
Unreadable filings 0
Joint filings 5
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 1
Sales at will 18
Transactions with no price 0
Shares from compensation/vesting 13,328,761
Sales filed before the plan box existed 1
History held since 12 Apr 2021